ACCP JOURNALS

143 Episodo

1. Leaders in Clinical Pharmacy: Jimmi Hatton Kolpek, Pharm.D., FCCP, FCCM, FNAP - Ep 103

   Publicado: 21/4/2023
2. Leaders in Clinical Pharmacy: Marie Chisholm-Burns, Pharm.D., Ph.D., MPH, MBA, FCCP, FASHP, FAST

   Publicado: 21/4/2023
3. Quality measures to help define the importance and value of CMM as a key component of population health management - Ep 102

   Publicado: 18/4/2023
4. PGY1 Pharmacy Residency Equivalency - Ep 101

   Publicado: 20/3/2023
5. Pre-lung transplant statin use on the development of primary graft dysfunction - Ep 100

   Publicado: 17/3/2023
6. Risk of bleeding with factor Xa inhibitors vs UFH in patients with AKI - Ep 99

   Publicado: 21/2/2023
7. Incorporating health equity into postgraduate pharmacy training - Ep 98

   Publicado: 15/2/2023
8. Clinical Practice Guidelines - Ep 97

   Publicado: 14/2/2023
9. What is a pharmacy fellowship? What kinds of fellowship are available? - Ep. 96

   Publicado: 13/2/2023
10. Rational polytherapy in patients with drug-resistant epilepsy - Ep 95

    Publicado: 24/1/2023
11. Vancomycin vs. Fidaxomicin for CDI - Ep 94

    Publicado: 6/1/2023
12. Bleeding risk with concomitant DOAC and fluconazole use - Ep 93

    Publicado: 15/12/2022
13. Perceptions of the Flip the Pharmacy initiative - Ep 92

    Publicado: 14/12/2022
14. Pharmacotherapy without Philosophy is Dangerous - Ep 90

    Publicado: 15/11/2022
15. Power of Placebos - Ep 89

    Publicado: 11/10/2022
16. Vancomycin AUC vs trough only guided dosing and the risk of AKI - Ep 88

    Publicado: 3/10/2022
17. Medication Errors: Lessons from the RaDonda Vaught Case and Steps for Action - Ep 87

    Publicado: 27/9/2022
18. Consensus Recommendations for Maintenance Immunosuppression in SOT - Ep 86

    Publicado: 31/8/2022
19. Health Equity & Clinical Pharmacy - Ep 85

    Publicado: 18/8/2022
20. Concomitant use of NSAIDs & misoprostol; Are NSAID-induced adverse events reduced? - Ep 84

    Publicado: 5/8/2022